Influence of extended mutations of the HIV-1 transframe protein p6 on Nef-dependent viral replication and infectivity in vitro (Q39875739)

15 September 2017

title

Influence of extended mutations of the HIV-1 transframe protein p6 on Nef-dependent viral replication and infectivity in vitro (English)

1 reference

15 September 2017

1 reference

Andreas Leiherer

1

1 reference

15 September 2017

Christine Ludwig

series ordinal

2

1 reference

15 September 2017

Ralf Wagner

series ordinal

3

1 reference

15 September 2017

language of work or name

English

0 references

publication date

9 March 2009

1 reference

15 September 2017

number of pages

11

1 reference

inferred from page(s)

published in

Virology

1 reference

15 September 2017

volume

387

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

200-210

1 reference

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

15 September 2017

cites work

2 references

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

7 January 2021

Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Sequence-specific resonance assignments of the 1H-NMR spectra and structural characterization in solution of the HIV-1 transframe protein p6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

The central region of human immunodeficiency virus type 1 p6 protein (Gag residues S14-I31) is dispensable for the virus in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Interactions of processed Nef (58-206) with virion proteins of HIV type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Protein Kinase C-mediated Phosphorylation of HIV-I Nef in Human Cell Lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Nef binds p6* in GagPol during replication of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Genetic and functional analysis of the human immunodeficiency virus (HIV) type 1-inhibiting F12-HIVnef allele.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Nef from human immunodeficiency virus type 1(F12) inhibits viral production and infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Anti-HIV viral interference induced by retroviral vectors expressing a nonproducer HIV-1 variant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Cleavage of recombinant and cell derived human immunodeficiency virus 1 (HIV-1) Nef protein by HIV-1 protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

The packaging and maturation of the HIV-1 Pol proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Alteration of the proline at position 7 of the HIV-1 spacer peptide p1 suppresses viral infectivity in a strain dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Selection of human immunodeficiency virus type 1 variants with an insertion mutation in the p6(gag) and p6(pol) genes under highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naïve individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Characterization of ribosomal frameshifting in HIV-1 gag-pol expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Importance of protease cleavage sites within and flanking human immunodeficiency virus type 1 transframe protein p6* for spatiotemporal regulation of protease activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Analysis of insertions and deletions in the gag p6 region of diverse HIV type 1 strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

cis expression of the F12 human immunodeficiency virus (HIV) Nef allele transforms the highly productive NL4-3 HIV type 1 to a replication-defective strain: involvement of both Env gp41 and CD4 intracytoplasmic tails.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Functional association between the nef gene product and gag-pol region of HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

The dimer interfaces of protease and extra-protease domains influence the activation of protease and the specificity of GagPol cleavage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Complete nucleotide sequence of the AIDS virus, HTLV-III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Complete nucleotide sequences of functional clones of the AIDS virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

The inhibition of HIV-1 protease by interface peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Analysis of HIV-1 CRF07_BC gag p6 sequences indicating novel deletions in the central region of p6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Enhancement of human immunodeficiency virus type 1 infectivity by Nef is producer cell-dependent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Nucleotide sequence of the AIDS virus, LAV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Polymorphisms in p1-p6/p6* of HIV Type 1 Can Delay Protease Autoprocessing and Increase Drug Susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Mfold web server for nucleic acid folding and hybridization prediction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

7 January 2021

gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

7 January 2021

Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.01.042

7 January 2021

10.1016/J.VIROL.2009.01.042

Identifiers

DOI

1 reference

15 September 2017

1 reference